Goldschmidt Pablo, Degorge Sandrine, Merabet Lilia, Chaumeil Christine
Laboratoire du Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts, Paris, France.
PLoS One. 2014 Jun 17;9(6):e94886. doi: 10.1371/journal.pone.0094886. eCollection 2014.
Biological samples, pharmaceuticals or food contain proteins, lipids, polymers, ammoniums and macromolecules that alter the detection of infectious agents by DNA amplification techniques (PCR). Moreover the targeted DNA has to be released from the complex cell walls and the compact nucleoprotein matrixes and cleared from potential inhibitors. The goal of the present work was to assess the efficiency of enzymatic pretreatments on infectious agents to make DNA available for further extraction and amplification.
Staphylococcus epidermidis, Streptococcus mitis, Propionibacterium acnes, Escherichia coli, Pseudomonas aeruginosa, Candida albicans, Aspergillus niger and Fusarium solani were mixed with an internal control virus and treated with: 1) proteinase K; 2) lyticase and 3) lyticase followed by proteinase K. DNAs was manually extracted using the QIAmp DNA Mini kit or the MagNA Pure Compact automate. DNA extraction yields and the inhibitors were assessed with a phocid Herpesvirus. Bacterial detection was performed using TaqMan real-time PCR and yeasts and filamentous Fungi with HRM (real-time PCR followed by high-resolution melting analysis).
Viral DNA was released, extracted and detected using manual and automatic methods without pre enzymatic treatments. Either the manual or the automatic DNA extraction systems did not meet the sensitivity expectations if enzymatic treatments were not performed before: lyticase for Fungi and Proteinase K for Bacteria. The addition of lyticase and proteinase K did not improve results. For Fungi the detection after lyticase was higher than for Proteinase K, for which melting analysis did not allow fungal specification.
Columns and magnetic beads allowed collecting DNA and separate PCR inhibitors. Detection rates cannot be related to DNA-avidity of beads or to elution but to the lack of proteolysis.
生物样本、药物或食品中含有蛋白质、脂质、聚合物、铵类和大分子,这些物质会通过DNA扩增技术(PCR)改变感染因子的检测结果。此外,目标DNA必须从复杂的细胞壁和紧密的核蛋白基质中释放出来,并清除潜在的抑制剂。本研究的目的是评估酶预处理对感染因子的作用效率,以便使DNA可用于进一步提取和扩增。
将表皮葡萄球菌、缓症链球菌、痤疮丙酸杆菌、大肠杆菌、铜绿假单胞菌、白色念珠菌、黑曲霉和茄病镰刀菌与一种内部对照病毒混合,并分别用以下方法处理:1)蛋白酶K;2)裂解酶;3)先使用裂解酶再使用蛋白酶K。使用QIAmp DNA Mini试剂盒或MagNA Pure Compact自动化仪器手动提取DNA。用海豹疱疹病毒评估DNA提取产量和抑制剂。使用TaqMan实时PCR检测细菌,使用HRM(实时PCR后进行高分辨率熔解分析)检测酵母和丝状真菌。
未经酶预处理,使用手动和自动方法均可释放、提取和检测病毒DNA。如果不进行酶预处理,无论是手动还是自动DNA提取系统均未达到灵敏度预期:真菌使用裂解酶,细菌使用蛋白酶K。添加裂解酶和蛋白酶K并未改善结果。对于真菌,使用裂解酶后的检测率高于蛋白酶K,蛋白酶K的熔解分析无法鉴定真菌种类。
柱和磁珠可用于收集DNA并分离PCR抑制剂。检测率与磁珠的DNA亲和力或洗脱无关,而与蛋白水解不足有关。